Application 208213
- Type
- ANDA
- Sponsor
- HETERO LABS LTD III
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ROFLUMILAST | ROFLUMILAST | TABLET;ORAL | 500MCG | No | No |
| 002 | ROFLUMILAST | ROFLUMILAST | TABLET;ORAL | 250MCG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 31722-623 | Roflumilast | Roflumilast | Camber Pharmaceuticals, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 49691 | ORIG | 2017-09-07 |